|
AT96130 |
[2-(4-Chloro-benzyloxy)-benzyl]-(4-pyrrolidin-1-yl-phenyl)-amine |
665013-65-0 |
C24H25ClN2O |
392.9211 |
VIEW DETAILS > |
|
BY65537 |
5-[[3-methoxy-4-(thiophen-2-ylmethoxy)phenyl]methylamino]-1,3-dihydrobenzimidazol-2-one |
665013-67-2 |
C20H19N3O3S |
381.4482 |
VIEW DETAILS > |
|
AT96177 |
[3-Methoxy-2-(thiophen-2-ylmethoxy)-benzyl]-(4-piperidin-1-yl-phenyl)-amine |
665013-69-4 |
C24H28N2O2S |
408.5563 |
VIEW DETAILS > |
|
AU16554 |
4-[(3-Methyl-thiophen-2-ylmethyl)-amino]-4H-[1,2,4]triazole-3-thiol |
665013-70-7 |
C8H10N4S2 |
226.3218 |
VIEW DETAILS > |
|
BL96512 |
3-[(4-chlorobenzyl)sulfanyl]-N-(2-ethoxybenzyl)-4H-1,2,4-triazol-4-amine |
665013-73-0 |
C18H19ClN4OS |
374.8877 |
VIEW DETAILS > |
|
BL96513 |
N-benzyl-N-{3-[(2-chlorobenzyl)sulfanyl]-4H-1,2,4-triazol-4-yl}amine |
665013-74-1 |
C16H15ClN4S |
330.8351 |
VIEW DETAILS > |
|
AT96151 |
Pentanoic acid {4-[(5-methyl-thiophen-2-ylmethyl)-amino]-phenyl}-amide |
665013-75-2 |
C17H22N2OS |
302.4344 |
VIEW DETAILS > |
|
BJ81639 |
NDM-1 inhibitor-2 |
665013-76-3 |
C9H9BrN4S |
285.1636 |
VIEW DETAILS > |
|
BT83473 |
N-[(4-ethoxyphenyl)methyl]-4-pyrrolidin-1-ylaniline |
665013-77-4 |
C19H24N2O |
296.4067 |
VIEW DETAILS > |
|
AT96140 |
[3-Bromo-4-(2,4-dichloro-benzyloxy)-5-methoxy-benzyl]-[3-(4-chloro-benzylsulfanyl)-[1,2,4]triazol-4-yl]-amine |
665013-78-5 |
C24H20BrCl3N4O2S |
614.7692 |
VIEW DETAILS > |